Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis
Open Access
- 16 February 2009
- journal article
- research article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 28 (1) , 20
Abstract
Hepatocellular carcinoma (HCC) is the most common tumor in the adult liver, with high relapse and mortality rates despite diverse treatment modalities. In this study, nicotinamide N-methyltransferase (NNMT), a key enzyme in drug metabolism, was investigated as a potential prognostic factor. Frozen tumors and non-cancerous surrounding tissues from 120 patients with primary HCC were studied. Expressions of NNMT and internal control genes were measured by real-time reverse-transcription PCR (RT-PCR). The relationship of NNMT mRNA level with clinicopathologic parameters and clinical outcome was evaluated. NNMT mRNA level is markedly reduced in HCCs compared to non-cancerous surrounding tissues (P < 0.0001), and NNMT expression in tumors was significantly correlated with tumor stage (P = 0.010). Moreover, stratification of patients based on tumor NNMT mRNA levels revealed that the patients who expressed higher NNMT mRNA levels tended to have a shorter overall survival (OS) time (P = 0.053) and a significantly shorter disease-free survival (DFS) time (P = 0.016). Both NNMT expression (P = 0.0096) and tumor stage (P = 0.0017) were found to be significant prognostic factors for DFS in a multivariate analysis. The results of this study indicated that NNMT gene expression is associated with tumor stage and DFS time in HCC cases. Because of the broad substrate specificity of NNMT, which could alter the efficacy and adverse effects of chemotherapy, NNMT merits further investigation regarding its role as a prognostic factor with a larger cohort of HCC patients.Keywords
This publication has 38 references indexed in Scilit:
- Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular CarcinomaCancer Research, 2008
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migrationOncogene, 2008
- Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cellsJournal of Cancer Research and Clinical Oncology, 2007
- Detection of the inferred interaction network in hepatocellular carcinoma from EHCO (E ncyclopedia of H epatocellular C arcinoma genes O nline)BMC Bioinformatics, 2007
- Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modificationExperimental & Molecular Medicine, 2006
- Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cellsHepatology, 2002
- Characterization of Nicotinamide Methyltransferase in Livers of Mice Bearing Ehrlich Ascites Tumors: Preferential Increase of ActivityTumor Biology, 1994
- Nicotinamide methylation in patients with cirrhosisJournal of Hepatology, 1994
- N1-Methylnicotinamide Level in the Blood after Nicotinamide Loading as Further Evidence for Malignant Tumor BurdenJapanese Journal of Cancer Research, 1991